Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Venlafaxine XR in elderly major depression
NCT00177528Phase 4Completed
- Sponsor
- University of Pittsburgh
- Start
- Oct 2000
- Primary completion
- Nov 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of venlafaxine in major depressive disorder (MDD), sponsored by University of Pittsburgh. Primary endpoints: Safety and tolerability of venlafaxine XR and Rate of Major Depression remission to treatment. Started Oct 2000; status: completed.
02
Drugs
venlafaxine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00177528.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00177528.